CONFERENCES

      Asian Aerosol Conference

      Asian Aerosol Conference (AAC) is a biennial conference that focuses on aerosol science and technology in the Asian region, with topics ranging from air pollution to aerosol instrumentation. The conference is aimed at scientists, engineers, and other professionals interested in the study of aerosols, and provides an opportunity for researchers in the Asian region to share their findings and collaborate with colleagues from around the world.

      12th Conference AAC 2022

      Date

      Jun 12, 2022 - Jun 16, 2022

      Location

      Taipei, Taiwan

      Online

      This conference brings over 160 speakers from more than 10 countries and hosts lectures that provide further insight into the adverse effects on health from aerosol exposure. 

      10th Conference AAC 2017

      Date

      Jul 02, 2017 - Jul 06, 2017

      Location

      Jeju-do, South Korea

      This conference includes a talk suggesting a link between airborne markers to biomarkers for secondhand smoke exposure of non-smoking staff in hospitality venues.

      See related posters

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.